Drug Shortage Report for PMS-CYTARABINE

Last updated on 2021-10-15 History
Report ID 147137
Drug Identification Number 02406764
Brand name PMS-CYTARABINE
Common or Proper name CYTARABINE
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) CYTARABINE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRATHECAL SUBCUTANEOUS INTRAVENOUS INTRATHECAL
Packaging size 100mg/5mL VIAL
ATC code L01BC
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-10-06
Actual start date 2021-10-14
Estimated end date 2021-12-22
Actual end date
Shortage status Actual shortage
Updated date 2021-10-15
Company comments
Health Canada comments
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-10-15 French Compare
v3 2021-10-15 English Compare
v2 2021-10-14 French Compare
v1 2021-10-14 English Compare